The clinical significance of the effect of somatostatin analogues on tumor shrinkage in patients with acromegaly has been further enhanced by the widespread use of long-acting somatostatin analogues as an alternative first-line therapy to surgical tumor resection. Here, SST is linked to acromegaly.